Oct 23 (Reuters) - Immutep Ltd IMM.AX :
* SIGNED MATERIAL TRANSFER AGREEMENT WITH UNIVERSITY HOSPITAL PILSEN, CZECH REPUBLIC
* AGREEMENT TO ENABLE PHASE II CLINICAL TRIAL EVALUATING EFTILAGIMOD ALPHA IN HOSPITALISED PATIENTS WITH COVID-19
* APPROVALS FROM CZECH REPUBLIC'S STATE INSTITUTE FOR DRUG CONTROL AND ETHICS COMMITTEE HAVE BEEN OBTAINED